From August 18 to 19, 2022, Fujian Haixi New Pharmaceutical Creation Co., Ltd. participated in the finals of the 11th China Innovation and Entrepreneurship Competition (Fujian Division) and the 10th Fujian Innovation and Entrepreneurship Competition hosted by the Fujian Provincial Department of Science and Technology in Fuzhou, and won the first prize of the Growth Enterprise Group.
The topic of our competition is "Innovative Business Format under the New Policy - The Road to the Industrial Chain of Pharmaceutical Listing License Holders". After years of intensive cultivation, we have developed a distinctive development model, that is, "imitation helps innovation and innovation drives the future". At the same time, we firmly grasp the policies entrusted to start-ups with R&D and innovation capabilities such as Haixi New Pharmaceuticals, such as the MAH system, the consistency evaluation of generic drugs and the national drug collection, which has effectively promoted the development and growth of the company. And achieved good results.
After four months, a total of 527 enterprises participated in the competition. After a fierce competition, the company "passed five levels and killed six generals" all the way. In the end, it won the first prize of the Fujian Division Finals of the 11th China Innovation and Entrepreneurship Competition with a total score of 92.5!